Inspire Medical Systems Gross Margin 2017-2024 | INSP

Current and historical gross margin for Inspire Medical Systems (INSP) over the last 10 years. The current gross profit margin for Inspire Medical Systems as of September 30, 2024 is %.
Inspire Medical Systems Gross Margin Historical Data
Date TTM Revenue TTM Gross Profit Gross Margin
2024-09-30 $0.76B $0.64B 84.66%
2024-06-30 $0.71B $0.60B 84.70%
2024-03-31 $0.66B $0.56B 84.57%
2023-12-31 $0.63B $0.53B 84.48%
2023-09-30 $0.57B $0.48B 84.21%
2023-06-30 $0.53B $0.44B 83.65%
2023-03-31 $0.47B $0.39B 83.69%
2022-12-31 $0.41B $0.34B 83.78%
2022-09-30 $0.35B $0.29B 84.15%
2022-06-30 $0.30B $0.26B 85.33%
2022-03-31 $0.26B $0.22B 85.50%
2021-12-31 $0.23B $0.20B 85.41%
2021-09-30 $0.20B $0.17B 85.07%
2021-06-30 $0.18B $0.15B 85.14%
2021-03-31 $0.13B $0.11B 85.07%
2020-12-31 $0.12B $0.10B 85.22%
2020-09-30 $0.10B $0.08B 85.42%
2020-06-30 $0.08B $0.07B 83.95%
2020-03-31 $0.09B $0.07B 83.91%
2019-12-31 $0.08B $0.07B 82.93%
2019-09-30 $0.07B $0.06B 80.56%
2019-06-30 $0.06B $0.05B 81.25%
2019-03-31 $0.06B $0.05B 80.70%
2018-12-31 $0.05B $0.04B 80.39%
2018-09-30 $0.04B $0.04B 81.82%
2018-06-30 $0.04B $0.03B 81.58%
2018-03-31 $0.03B $0.03B 81.82%
2017-12-31 $0.03B $0.02B 82.14%
Sector Industry Market Cap Revenue
Medical Medical Information Systems $5.276B $0.625B
Inspire Medical Systems Inc. is a medical technology company. It focused on the development and commercialization of solutions for obstructive sleep apnea. The company's proprietary Inspire therapy is a neurostimulation technology which provides treatment for moderate to severe obstructive sleep apnea. Inspire Medical Systems Inc.is based in Minnesota, United States.
Stock Name Country Market Cap PE Ratio
Tempus AI (TEM) United States $8.497B 0.00
Hims & Hers Health (HIMS) United States $5.141B 130.72
Privia Health (PRVA) United States $2.533B 211.10
Enovis (ENOV) United States $2.529B 17.15
IRhythm Technologies (IRTC) United States $2.362B 0.00
Azenta (AZTA) United States $2.001B 99.78
Omnicell (OMCL) United States $1.964B 64.26
Clover Health Investments (CLOV) United States $1.644B 0.00
10x Genomics (TXG) United States $1.643B 0.00
Schrodinger (SDGR) United States $1.378B 0.00
Phreesia (PHR) United States $1.072B 0.00
Butterfly Network (BFLY) United States $0.650B 0.00
Standard BioTools (LAB) United States $0.562B 0.00
Talkspace (TALK) United States $0.522B 0.00
Fulgent Genetics (FLGT) United States $0.520B 0.00
Definitive Healthcare (DH) United States $0.483B 83.60
Health Catalyst (HCAT) United States $0.459B 0.00
TruBridge (TBRG) United States $0.244B 71.22
Pulmonx (LUNG) United States $0.237B 0.00
SOPHiA GENETICS SA (SOPH) Switzerland $0.214B 0.00
American Well (AMWL) United States $0.122B 0.00
EUDA Health Holdings (EUDA) Singapore $0.107B 0.00
P3 Health Partners (PIII) United States $0.075B 0.00
HeartBeam (BEAT) United States $0.067B 0.00
111 (YI) China $0.053B 0.00
CareCloud (CCLD) United States $0.046B 0.00
Zepp Health (ZEPP) China $0.040B 0.00
SHL Telemedicine (SHLT) Israel $0.040B 0.00
Outset Medical (OM) United States $0.039B 0.00
Movano (MOVE) United States $0.020B 0.00
Bullfrog AI Holdings (BFRG) United States $0.019B 0.00
Streamline Health Solutions (STRM) United States $0.014B 0.00
Strata Skin Sciences (SSKN) United States $0.013B 0.00
ImmunoPrecise Antibodies (IPA) Canada $0.012B 0.00
MSP Recovery (LIFW) United States $0.010B 0.00
Precipio (PRPO) United States $0.009B 0.00
Healthcare Triangle (HCTI) United States $0.006B 0.00
Mobile-health Network Solutions (MNDR) Singapore $0.006B 0.00
Predictive Oncology (POAI) United States $0.004B 0.00
Syra Health (SYRA) United States $0.004B 0.00
HeartSciences (HSCS) United States $0.002B 0.00
Zhongchao (ZCMD) China $0.002B 0.00
Tivic Health Systems (TIVC) United States $0.002B 0.00
Future Health ESG (FHLT) United States $0.000B 0.00
MDxHealth SA (MDXH) Belgium $0.000B 0.00
Nyxoah SA (NYXH) Belgium $0.000B 0.00